“Gene Therapy that Everyone can Process means we dream of using our biotech development and process data to revolutionize our unique space within precision medicine and healthcare, making rare and complex medicines truly more accessible to everyone.” - Medvectors Development Team
From single molecule, smaller virtual company’s… to large scale established pharmaceuticals... Medvectors can become a new precision bioprocessing partner for all regulatory ready solutions… all with Privacy and Security built into our platform’s DNA.
We do this by giving small to medium size biopharma companies access to their own platform that “supercharges” all development process time using inside of a next generation bioprocessing technology. For those interested in traversing this exciting new territory with us, we can be your new CMO service or partner of the future.
Medvectors offers a truly Next Generation Biotechnology Processing Platform with trusted results. We understand everyone deserves a secure, private place to explore and understand their own research and development data and we have put this at the core of our philosophy. This means our client’s are in control of deciding what information they want to learn and what you want to secure or share.
Get Access to highly managed accounts that deliver the experience needed to build the best process for you. Our rigorous standards ensure quality science and service including:
Genetic Risk and Carrier Status reports that meet FDA criteria for being scientifically and clinically valid
All samples and processes within CLIA-certified in our CAP-accredited core lab
All sample data collection processes and reports are FDA-cleared for use with our reports
Our lab results are manufactured in accordance with FDA's Good Manufacturing Practice regulations
Our facility uses industry standard processes, and a well-established and reliable processing platform for analyzing gene therapy data across multiple already well-established and reliable processes and practices
Our team of scientists and biotech experts use a robust process to develop reports that ensure validity, and are available to chat with clients upon any questions or concerns throughout development.
Our report percentages and digital testing data is derived from our powerful, well-tested system that provides clients with processing data estimates down to the 0.1%
The Current Gene Therapy Space, The future, and us…